iBio, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $100 |
Gross Profit | -250 | -241 | -189 |
EBITDA | -7,458 | -8,711 | -5,395 |
EBIT | -7,708 | -8,952 | -5,684 |
Net Income | -7,730 | -8,993 | -5,720 |
Net Change In Cash | 0 | 0 | 100 |
Free Cash Flow | -6,095 | -5,757 | -5,697 |
Cash | 47,631 | 28,672 | 28,111 |
Basic Shares | 119,600 | 99,133 | 52,981 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $100 | $400 | $225 | $50 |
Gross Profit | 400 | 225 | 50 | |
EBITDA | -17,039 | -14,021 | -28,107 | |
EBIT | -18,165 | -15,271 | -29,311 | |
Net Income | -33,044 | -18,377 | -24,907 | -29,311 |
Net Change In Cash | 100 | 400 | 225 | 50 |
Free Cash Flow | -23,796 | -15,320 | -18,764 | -36,174 |
Cash | 56,395 | 8,582 | 14,210 | 7,326 |
Basic Shares | 104,060 | 10,499 | 3,831 | 612 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.06 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.29 |
2025-06-30 | -$0.32 |